简介：Cancercellsarewelldocumentedtorewiretheirmetabolismandenergyproductionnetworkstosupportandenablerapidproliferation,continuousgrowth,survivalinharshconditions,invasion,metastasis,andresistancetocancertreatments.SinceDr.OttoWarburg’sdiscoveryaboutalteredcancercellmetabolismin1930,thousandsofstudieshaveshedlightonvariousaspectsofcancermetabolismwithacommongoaltofindnewwaysforeffectivelyeliminatingtumorcellsbytargetingtheirenergymetabolism.Thisreviewhighlightstheimportanceofthemainfeaturesofcancermetabolism,summarizesrecentremarkableadvancesinthisfield,andpointsoutthepotentialstotranslatethesescientificfindingsintolife-savingdiagnosisandtherapiestohelpcancerpatients.

简介：

简介：Prostatic演算是普通的并且与前列腺的发炎被联系。最近，这发炎可以与前列腺carcinogenesis被联系，这被建议了。这研究的目的是在前列腺活体检视标本调查在prostatic演算和前列腺癌症(PCa)之间的关系。我们回顾地分析了经历了transrectalultrasonography(TRUS)和在2005年1月和2008年1月之间的前列腺活体检视的417个连续病人。基于活体检视调查结果，病人们被划分成良性的prostatic增生和PCa组。TRUS被用来检测prostatic演算并且测量前列腺体积。在PCa风险和年龄，浆液总数PSA层次，前列腺体积，和prostatic演算之间的关联被分析。耐心的年龄和PSA，以及在活体检视标本的prostatic演算的频率，在两个之间显著地不同这些组(P<0.05)。在PCa组，没有prostatic演算，格利森分数(GS)比在病人在有prostatic演算的病人是更高的(P=0.023)。用multivariate逻辑回归分析，我们发现了那耐心的年龄，浆液总数PSA和前列腺体积是为PCa的风险因素(P=0.001)，但是prostatic演算的存在没与PCa的增加的风险被联系(P=0.13)。在结论，尽管prostatic演算的存在没被显示是为PCa的一个风险因素，prostatic演算在有PCa的病人是更普通的并且在这些人之中与更高的GS被联系。

简介：

简介：Allogeneicstemcelltransplantation(allo-SCT)isapotentialcureforpatientswithmalignantlymphomathatisbasedonthegraft-versus-lymphoma(GVL)effect.Myeloablativeconditioningallo-SCTisassociatedwithhighmortalityandmorbidity,particularlyinpatientsolderthan45years,heavilypretreatedpatients(priorhematopoieticstemcelltransplantationormorethantwolinesofconventionalchemotherapy)orpatientsaffectedbyothercomorbidities.Therefore,conventionalallo-SCTisrestrictedtoyoungerpatients(<50to55years)ingoodphysicalcondition.Overthelastdecade,allo-SCTwithreduced-intensityconditioning(RIC-allo-SCT)hasbeenincreasinglyusedtotreatpatientswithlymphoma.Thistreatmentisassociatedwithlowertoxicityandsubstantialdecreaseintheincidenceoftransplant-relatedmortality,andhasthepotentialtoleadtolong-termremissions.Therefore,patientswhoarenotsuitabletoundergoconventionalallo-SCTcanbenefitfromthepotentiallycurativeGVLeffectsofallo-SCT.AlthoughRIC-allo-SCThasimprovedthesurvivaloflymphomapatients,highpost-transplantrelapseratesordiseaseprogressionmainlyresultsintreatmentfailure.Thus,furtherimprovementisclearlyneeded.TheroleandtimingofRIC-allo-SCTinthetreatmentoflymphomaremainsunclear.Therefore,moreprospectivestudiesshouldclarifytheeffectivenessofthismethod.Inthisarticle,wereviewtherecentliteratureonRIC-allo-SCTasatreatmentformajorlymphomasubtypes.Areasthatrequirefurtherinvestigationinthecontextofclinicaltrialsarealsohighlighted.

简介：ＴＵＭＯＲＮＥＣＲＯＳＩＳＦＡＣＴＯＲ－αＡＬＴＥＲＳＰＲＯＴＥＩＮＭＥＴＡＢＯＬＩＳＭＡＮＤＣＥＬＬ－ＣＹＣＬＥＫＩＮＥＴＩＣＳＩＮＭＡＬＩＧＮＡＮＴＴＵＭＯＲＹｅＳｈｅｎｇｌｏｎｇ叶胜龙；ＴａｎｇＺｈａｏｙｏｕ汤钊猷；ＢｒｕｃｅＲＢｉｓｔｒｉａｎ...

简介：

简介：

简介：尽管免疫系统拥有工具对癌症作出回应，它经常没能控制恶意的传播。尽管如此，装备内长的免疫释放强壮的antitumor回答比常规治疗有重要优点。这评论探索一些可得到的选择完成这，在有刺激免疫系统并且授权更强壮的antitumor回答的肿瘤抗原的种痘上集中第一。我们然后比较并且形成对照声发有用淋巴细胞转移的T的采纳治疗的记录得好的药品潜力的种痘的有限临床的成功。最后，我们用与受体一起利用allogeneicT房间全部剧目的房间受体(TCR)基因转移策略为定义MHC/peptide联合在vitro选择了的T加亮新奇途径，作为癌症的抗原特定的基因治疗的一个基础。

简介：

简介：Acupuncture,asacomplementarytherapy,hasbeenusedtomanagethecancerassociatedsymptomsofcancerpatients.Toidentifytheefficacyandsafetyofacupunctureinthemanagementofcancer,thisreviewcriticallyanalysestherelevantpublicationsincludingbothexperimentalandclinicalstudies.Themajorityofstudiessuggestthatacupunctureeffectivelyrelievessomecancerrelatedsymptomssuchascancerpain,andsomeadverseeffectscausedbythecancerconventionaltreatmentssuchasnausea,vomiting,neutropeniaandxerostomia.

简介：Colorectalcancer(CRC)isthesecondmostcommoncancerinwomenandthethirdmostcommoninmenglobally.CRCarisesfromoneoracombinationofchromosomalinstability,CpGislandmethylatorphenotype,andmicrosatelliteinstability.Geneticinstabilityisusuallycausedbyaneuploidyandlossofheterozygosity.Mutationsinthetumorsuppressororcellcyclegenesmayalsoleadtocellulartransformation.Similarly,epigeneticand/orgeneticalterationsresultinginimpairedcellularpathways,suchasDNArepairmechanism,mayleadtomicrosatelliteinstabilityandmutatorphenotype.Non-codingRNAs,moreimportantlymicroRNAsandlongnon-codingRNAshavealsobeenimplicatedatvariousCRCstages.Understandingthespecificmechanismsoftumorigenesisandtheunderlyinggeneticandepigenetictraitsiscriticalincomprehendingthediseasephenotype.Thispaperreviewsthesemechanismsalongwiththerolesofvariousnon-codingRNAsinCRCs.

简介：AbstractPatient-derived tumor organoids (PDOs) currently represent important modeling tools in pre-clinical investigation of malignancies. Organoid cultures conserve the genetic and phenotypic characteristics of the original tumor and maintain its heterogeneity, allowing their application in many research fields. PDOs derived from colorectal cancer (CRC) have been used for genetic modeling to investigate the function of driver genes. Some researchers have been exploring the value of CRC PDOs in chemotherapy, targeted therapy, and radiotherapy response prediction. The successful generation of PDOs derived from CRC could deepen our understanding of CRC biology and provide novel tools for cancer modeling, for realizing precision medicine by assessing specimens from individual patients ex vivo. The present review discusses recently reported advances in CRC PDOs and the challenges they face as pre-clinical models in CRC research.

简介：

简介：Duetoconcernsregardingtheoverlappingfiguresinthisreviewthatareidenticaltothosecontainedinareviewarticlethatwehaveco-authoredandpublishedearlier,weretracttheabovepaperwepublishedinCellResearch.Weapologizeforanyconfusionthatmaybecausedbythismatter,althoughwestandbythescientificcontentscontainedintheCellResearchpaper.

简介：ChineseJournalofCancerResearch,aninternationalbiomedicaljournaleditedandpublishedquarterlyinEnglishbyChinaAnti-CancerAssociation(CACA),isacomprehensiveacademicjournal,aimingtoreflectprimarilythecreativeorinnovativeachievementsinallfieldsofcancerresea...

简介：InSeptember2013,theTranslationalAndrologyandUrology(TAU)launchedafocusissueon'ProstateCancer',whichwasguest-editedbyDr.Jer-TsongHsiehandDr.GaneshRajfromUniversityofTexasSouthwesternMedicalCenteratDallas,USA.Inthisfocusissue,Dr.RajandDr.Hsiehinvitedaninternationalexpertpanelofcliniciansandbasicscientiststooutlinecurrentchallengesofprostatecancertreatment

简介：

简介：在xenotropic之间的潜在的协会鼠科的白血球过多症自从2006，病毒相关的gammaretrovirus(XMRV)和前列腺癌症(PCa)被记录了。查明这个协会是否是原因的，为推进我们PCa的生物机制的理解是重要的。总结可得到的信息在上流行病学并且协会的实验室调查结果，我们进行了PubMed电子数据库的文学搜索(从2006年3月到2011年2月)那检验了在XMRV和PCa之间的协会识别相关出版研究。尽管几研究显示出在XMRV和PCa之间的积极协会，更最近的研究没支持这个结论。积极调查结果可能由于人的样品的污染。进一步的研究被需要澄清这个协会。

简介：AbstractObjective:Alternative splicing can generate various structural and functional protein isoforms. Recently, accumulating evidence shows a relationship between alternative splicing and cancer. Cancer is a complex and chronic disease that involves malignant transformation. In this review, we consider alternative splicing events in relation to the hallmarks of cancer cells, and discuss current therapies to treat cancer-related to alternative splicing.Data sources:Data cited in this article are from the PubMed and Embase database, primarily focusing on research published from 2000 to 2018.Study selection:Articles were selected with the search terms "alternative splicing," "cancer cell," "tumor microenvironment," and "therapy."Results:Alternative splicing plays an important role in tumorigenesis, development, and escape from cell death. Taking this trait of cancer cells into consideration will allow more definite diagnoses of cancer, and allow the development of more effective medicines to intervene in cancer that could focus on controlling alternative splicing or competitively binding to the final products.Conclusions:Alternative splicing is common in cancer cells. Consideration of alternative splicing may allow different strategies for cancer therapy or the identification of novel biomarkers for cancer diagnosis.